Sign Out
Pregnancy: Methyldopa has been used under close medical supervision for the treatment of hypertension during pregnancy. There was no clinical evidence that Methyldopa caused foetal abnormalities or affected the neonate.
Published reports of the use of Methyldopa during all trimesters indicate that if this drug is used during pregnancy, the possibility of fetal harm appears remote.
Methyldopa crosses the placental barrier and appears in cord blood.
Although no obvious teratogenic effects have been reported, the possibility of fetal injury cannot be excluded and the use of the drug in women who are, or may become pregnant requires that anticipated benefits be weighed against possible risks.
Breastfeeding: Methyldopa appears in breast milk. The use of the drug in breastfeeding mothers requires that anticipated benefits be weighed against possible risks.
Continue with Google